Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Aug. 13, 1999

Viron Therapeutics awarded US patent for use of viral proteins as antiinflammatory agents

Aug. 6, 1999

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

Aug. 5, 1999

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Aug. 3, 1999

Mutual recognition granted to Agrippal; vaccine to be marketed throughout Europe

Aug. 2, 1999

Aviron and Medeva extend FluMist collaboration

Aug. 2, 1999

Cangene product for prevention of hemolytic disease approved in U.K.

July 29, 1999

Avant Immunotherapeutics' rotavirus vaccine effective in infants

July 29, 1999

FDA advisory committee OKs safety and efficacy of Rapamune

July 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...